| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.1876D |
| P356 | DOI | 10.1073/PNAS.0509451103 |
| P932 | PMC publication ID | 1413648 |
| P698 | PubMed publication ID | 16446436 |
| P5875 | ResearchGate publication ID | 7328346 |
| P50 | author | Stephanie Schüller | Q47097350 |
| Paul Dean | Q57269178 | ||
| P2093 | author name string | Marc Maresca | |
| Alan D Phillips | |||
| Brendan Kenny | |||
| P2860 | cites work | Diarrheagenic Escherichia coli | Q24533466 |
| Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro | Q33752405 | ||
| Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG | Q33768868 | ||
| The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition | Q33843603 | ||
| SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system | Q33883322 | ||
| Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection | Q33902441 | ||
| Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. | Q34003963 | ||
| Management of infectious diarrhoea | Q35598312 | ||
| Enteropathogenic Escherichia coli: unravelling pathogenesis | Q36010824 | ||
| EPEC's weapons of mass subversion | Q36032356 | ||
| Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli | Q39512479 | ||
| Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. | Q39830323 | ||
| Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. | Q39996509 | ||
| Differential regulation of Na+/H+ exchange isoform activities by enteropathogenic E. coli in human intestinal epithelial cells | Q40568292 | ||
| Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions | Q40997195 | ||
| A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model | Q41138277 | ||
| Kinetic separation and characterization of three sugar transport modes in Caco-2 cells | Q41200175 | ||
| Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line | Q41352353 | ||
| Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells | Q41862570 | ||
| Effects of enteropathogenic Escherichia coli on microvillar membrane proteins during organ culture of rabbit intestinal mucosa | Q41874908 | ||
| Organ culture of rabbit ileum as a model for the investigation of the mechanism of intestinal damage by enteropathogenic Escherichia coli | Q43199098 | ||
| Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice | Q44375935 | ||
| More than apical: Distribution of SGLT1 in Caco-2 cells | Q44457706 | ||
| Enteropathogenic Escherichia coli (EPEC)-- a crafty subversive little bug. | Q44980808 | ||
| Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. | Q45144471 | ||
| Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells | Q48042079 | ||
| Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition | Q48217964 | ||
| The human Na+-glucose cotransporter is a molecular water pump | Q48939861 | ||
| Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. | Q52546261 | ||
| Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. | Q52560716 | ||
| Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. | Q53861786 | ||
| Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. | Q54517340 | ||
| A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. | Q54574143 | ||
| Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract | Q56967958 | ||
| The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin | Q77936911 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| enteropathogen | Q63500873 | ||
| P304 | page(s) | 1876-1881 | |
| P577 | publication date | 2006-01-30 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins | |
| P478 | volume | 103 |
| Q37690960 | A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis |
| Q46479145 | Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes |
| Q43621625 | Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens |
| Q35191956 | Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. |
| Q24293521 | Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function |
| Q33528372 | Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors |
| Q38325835 | Cell-surface nucleolin is sequestered into EPEC microcolonies and may play a role during infection |
| Q30010247 | Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells. |
| Q38816242 | Cultured enterocytes internalise bacteria across their basolateral surface for, pathogen-inhibitable, trafficking to the apical compartment |
| Q33326978 | Deciphering interplay between Salmonella invasion effectors |
| Q33775617 | Direct injection of functional single-domain antibodies from E. coli into human cells |
| Q33358967 | Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines |
| Q39413863 | Do Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease? |
| Q42230943 | Dynamics of brush border remodeling induced by enteropathogenic E. coli |
| Q38724200 | EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity |
| Q24596978 | Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea |
| Q35888490 | Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. |
| Q38926009 | Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo |
| Q52688929 | Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation. |
| Q41506828 | Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration |
| Q38021502 | Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms |
| Q26996996 | Enteropathogenic E. coli: breaking the intestinal tight junction barrier |
| Q40153854 | Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. |
| Q37055770 | Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. |
| Q37391808 | Enteropathogenic Escherichia coli inhibits intestinal vitamin B1 (thiamin) uptake: studies with human-derived intestinal epithelial Caco-2 cells |
| Q41433037 | Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases |
| Q35784058 | Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributes to physiological alterations in intestinal epithelial cells |
| Q38452303 | Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination |
| Q34177961 | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements |
| Q26830066 | Enteropathogenic escherichia coli infection in children |
| Q39418879 | Escherichia coli-induced epithelial hyporesponsiveness to secretagogues is associated with altered CFTR localization |
| Q34889643 | Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo |
| Q27025808 | From Escherichia coli heat-stable enterotoxin to mammalian endogenous guanylin hormones |
| Q38101247 | From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol |
| Q38830802 | Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis. |
| Q35122829 | In vitro exposure to Escherichia coli decreases ion conductance in the jejunal epithelium of broiler chickens |
| Q41368628 | Increased intracellular calcium level and impaired nutrient absorption are important pathogenicity traits in the chicken intestinal epithelium during Campylobacter jejuni colonization. |
| Q38007348 | Infection strategies of enteric pathogenic Escherichia coli |
| Q37843682 | Infectious diarrhea: Cellular and molecular mechanisms |
| Q64083367 | Influence of the intestinal microbiota on disease susceptibility in kittens with experimentally-induced carriage of atypical enteropathogenic Escherichia coli |
| Q34576318 | Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte model |
| Q27012975 | Interspecies communication in the gut, from bacterial delivery to host-cell response |
| Q37780578 | LEEways: tales of EPEC, ATEC and EHEC. |
| Q37055281 | Mimicking small G-proteins: an emerging theme from the bacterial virulence arsenal |
| Q43717369 | Molecular mechanisms of Escherichia coli pathogenicity |
| Q33582232 | Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa |
| Q38912737 | Pathogen-induced secretory diarrhea and its prevention |
| Q37264192 | Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines |
| Q38084050 | Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic |
| Q36911360 | Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q30432222 | Remodeling of the intestinal brush border underlies adhesion and virulence of an enteric pathogen |
| Q37816402 | Sticky situation: localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium |
| Q24310471 | The EHEC-host interactome reveals novel targets for the translocated intimin receptor |
| Q37777278 | The EspF effector, a bacterial pathogen's Swiss army knife |
| Q34571628 | The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7. |
| Q55433458 | The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea. |
| Q41971348 | The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector |
| Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
| Q34921824 | The effector repertoire of enteropathogenic E. coli: ganging up on the host cell |
| Q28478223 | The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors |
| Q28474712 | The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction |
| Q41870508 | The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity |
| Q37557346 | The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea |
| Q30480560 | The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. |
| Q40171429 | Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. |
| Q36193949 | Transmissible Gastroenteritis Virus Infection Enhances SGLT1 and GLUT2 Expression to Increase Glucose Uptake |
| Q38735104 | Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption. |
Search more.